Gentel Licenses OHSU Viral Antigens for its Simian Assay | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gentel Biosciences today announced a licensing deal with Oregon Health & Science University covering viral antigens for use on its Colony Surveillance Assays.

The deal is for worldwide commercial use, and the addition of the antigens complements Gentel's strategy to grow its product line to support translational research disease models, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.